Clinical Trials · NCT07426094
PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer
- Phase
- Phase 2/Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Affidea Nu-med Center of Oncological DIagnostics and Therapy
- Enrollment
- 600
- Start date
- Mar 2026
- Locations
- 1 site, Poland
- Primary endpoint
- Metastasis-Free Survival (MFS)